Pliant Therapeutics (PLRX) Revenue (2020 - 2023)

Pliant Therapeutics (PLRX) has 4 years of Revenue data on file, last reported at $248000.0 in Q2 2023.

• Revenue for Q2 2023 came in at $248000.0, down 95.03% year-over-year; the trailing twelve-month figure through Mar 2024 was $248000.0 (down 97.46% YoY), and the FY2023 annual result was $1.6 million, down 83.69% from the prior year.
• Revenue declined to $248000.0 in Q2 2023 per PLRX's latest filing, from $1.3 million in the prior quarter.
• Over five years, Revenue peaked at $28.9 million in Q1 2020 and troughed at $248000.0 in Q2 2023.
• A 4-year average of $4.3 million and a median of $2.0 million in 2021 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2023: Revenue surged 178.87% in 2022, then plunged 95.03% in 2023.
• A 4-year view of Revenue shows it stood at $4.5 million in 2020, then slumped by 55.23% to $2.0 million in 2021, then dropped by 1.7% to $2.0 million in 2022, then tumbled by 87.38% to $248000.0 in 2023.
• Business Quant data shows PLRX's Revenue at $248000.0 in Q2 2023, $1.3 million in Q1 2023, and $2.0 million in Q4 2022.